Abstract
LYMPHOCYTE migration from blood into tissue depends on integrin-mediated adhesion to endothelium1–4. Adhesion requires not only integrin ligands on the endothelium, but also activation signals because T-cell integrins cannot bind well until they are activated. The physiological 'triggers' for T-cell adhesion are unknown, but cytokines may be good candidates as they are released during inflammation and trigger adhesion in neutrophils and monocytes2,5,6. We have identified a cytokine, macrophage inflammatory protein-1β (MIP-1β), that induces both chemotaxis and adhesion of T cells; MIP-1β is most effective at augmenting adhesion of CD8+ T cells to the vascular cell adhesion molecule VCAM-1. We reasoned that, as cytokines in vivo will be rapidly washed away, MIP-1β might be bound to endothelial surfaces and so induce adhesion in its immobilized form. Here we show that: (1) M IP-1β is present on lymph node endothelium; (2) immobilized MIP-1β induces binding of T cells to VCAM-1 in vitro. M IP-1β was immobilized by binding to proteoglycan: a conjugate of heparin with bovine serum albumin and cellular proteoglycan CD44 were both effective. We propose that MIP-1β and other cytokines with glycosaminoglycan-binding sites will bind to and be presented by endothelial proteoglycans to trigger adhesion selectively not only of lymphocyte subsets, but also of other cell types.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Springer, T. A. Nature 346, 425–434 (1990).
Butcher, E. C. Cell 67, 1033–1036 (1991).
Shimizu, Y., Newman, W., Tanaka, Y. & Shaw, S. Immun. Today 13, 106–112 (1992).
Hynes, R. O. Cell 69, 11–25 (1992).
Shaw, L. M. & Mercurio A. M. J. exp. Med. 169, 303–308 (1989).
Araaout, M. A., Wang, E. A., Clark, S. C. & Sieff, C. A. J. clin. Invest. 78, 591–601 (1986).
Oppenheim, J. J., Zachariae, C. D. C., Mukaida, N. & Matsushima, K. A. Rev. Immun. 9, 617–648 (1991).
Schall, T. J. Cytokine 3, 165–183 (1991).
Wolpe, S. D. et al. J. exp. Med. 167, 570–581 (1988).
van Seventer, G. A. et al. J. exp. Med. 174, 901–913 (1991).
Schall, T. J., Bacon, K., Toy, K. J. & Goeddel, D. V. Nature 347, 669–671 (1990).
Rot, A. Immun. Today 13, 291–294 (1992).
Tanaka, Y., Adams, D. H. & Shaw, S. Immun. Today (in the press).
Jackson, R. L., Busch, S. J. & Cardin, A. D. Physiol. Rev. 71, 481–539 (1991).
Ruoslahti, E. & Yamaguchi, Y. Cell 64, 867–869 (1991).
Nathan, C. & Sporn, M. J. Cell. Biol. 113, 981–986 (1991).
Klagsbrun, M. & Baird, A. Cell 67, 229–231 (1991).
Gordon, M. Y., Riley, G. P., Watt, S. M. & Greaves, M. F. Science 326, 403–405 (1987).
Haynes, B. F., Telen, M. J., Hale, L. P. & Denning, S. M. Immun. Today 10, 423–428 (1989).
Brown, T. A., Bouchard, T., St John, T., Wayner, E. & Carter, W. G. J. Cell Biol. 113, 207–211 (1991).
Pals, S. T. et al. J. Immun. 143, 851–857 (1989).
Berg, E. L. et al. Immun. Rev. 108, 5–18 (1989).
Sherry, B. et al. J. exp. Med. 168, 2251–2259 (1988).
Zipfel, P. F., Balke, J., Irving, S. G., Kelly, K. & Siebenlist, U. J. Immun. 142, 1582–1590 (1989).
Huber, A. R., Kunkel, S. L., Todd, R. F. III & Weiss, S. J. Science 254, 99–102 (1991).
Kuijpers, T. W., Hakkert, B. C., Hart, M. H. & Roos, D. J. Cell. Biol. 117, 565–572 (1992).
Wight, T. N. Arteriosclerosis 9, 1–20 (1989).
Kojima, T., Shworak, N. W. & Rosenberg, R. D. J. biol. Chem. 267, 4870–4877 (1992).
Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B. & Seed, B. Cell 61, 1303–1313 (1990).
Stamenkovic, I., Aruffo, A., Amiot, M. & Seed, B. EMBO J. 10, 343–348 (1991).
Zimmerman, G. A., Prescott, S. M. & Mclntyre, T. M. Immun. Today 13, 93–99 (1992).
Pardi, R., Inverardi, L. & Bender, J. R. Immun. Today 13, 224–231 (1992).
Lo, S. K. et al. J. exp. Med. 173, 1493–1500 (1991).
Horgan, K. J. & Shaw, S. in Current Protocols in Immunology (eds Coligan, J. E., Kruisbeek, A. M., Margulies, D. H., Shevach, E. M. & Strober, W.) 7.4.1–7.4.5 (Wiley Interscience, New York, 1991).
Adams, D. H. et al. J. Immun. 147, 609–612 (1991).
Larsen, C. G., Anderson, A. O., Appella, E., Oppenheim, J. J. & Matsushima, K. Science 243, 1464–1466 (1989).
Tanaka, Y. et al. J. exp. Med. 176, 245–253 (1992).
Guo, N. et al. Proc. natn. Acad. Sci. U.S.A. 89, 3040–3044 (1992).
Shimizu, Y., van Seventer, G. A., Siraganian, R., Wahl, L. & Shaw, S. J. Immun. 143, 2457–2463 (1989).
Adams, D. H., Hubscher, S. G., Shaw, J., Rothlein, R. & Neuberger, J. M. Lancet 2, 1122–1125 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tanaka, Y., Adams, D., Hubscher, S. et al. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-lβ. Nature 361, 79–82 (1993). https://doi.org/10.1038/361079a0
Issue Date:
DOI: https://doi.org/10.1038/361079a0
This article is cited by
-
Direct interaction of TrkA/CD44v3 is essential for NGF-promoted aggressiveness of breast cancer cells
Journal of Experimental & Clinical Cancer Research (2022)
-
Liver sinusoidal endothelial cells — gatekeepers of hepatic immunity
Nature Reviews Gastroenterology & Hepatology (2018)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.